Prices delayed by at least 15 minutes | Print
Genflow Biosciences PLC (GENF)
ORD GBP0.0003Open
2.15p
Previous close
2.15p
Trade high
2.24p
Volume
1,948,848
Year high
3.90p
Year low
1.32p
Dividend yield
-
Market capitalisation
£7.61 mn
P/E ratio
-
ISIN
GB00BP2C3V08
This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence ofage-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 17/05/2024 | 04:27:08 | 2.16 | 62,251 | 1,344.62 |
| 17/05/2024 | 03:57:49 | 2.16 | 15 | 0.32 |
| 17/05/2024 | 03:26:26 | 2.156 | 50,000 | 1,078.00 |
| 17/05/2024 | 03:26:02 | 2.16 | 50,000 | 1,080.00 |
| 17/05/2024 | 03:20:11 | 2.16 | 500 | 10.80 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.